Why Did Mylan Sit On The News It Spent Nearly Half A Billion Dollars On Buying Rights?
- 6 years ago
EpiPen maker Mylan made a $463m agreement for the worldwide rights for a commercial product.
BI reports the July deal wasn't formally announced to the public and investors via a news release.
Nor was it discussed as part of the company's second quarter earnings on August 8th.
Wells Fargo analyst David Maris first spotted the deal--and wasn't happy with the Mylan's conduct.
We believe that investors should know more about the details of this deal, especially given its size.
BI reports the July deal wasn't formally announced to the public and investors via a news release.
Nor was it discussed as part of the company's second quarter earnings on August 8th.
Wells Fargo analyst David Maris first spotted the deal--and wasn't happy with the Mylan's conduct.
We believe that investors should know more about the details of this deal, especially given its size.